← Back to catalogue

Aptima®

FDA UDI

Class I (US FDA UDI)

by Hologic, Inc.

Identity

Trade Name
Aptima® FDA UDI
Generic Name
Multiple-type sexually transmitted pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Aptima® General Purpose Reagents, 250 test, box 2 of 2 (2°C to 8°C box). The Aptima® General Purpose Reagents (GPRs) feature Transcription-Mediated Amplification (TMA®) and Hybridization Protection Assay (HPA) technologies. Aptima® GPRs may be used to facilitate the development of tests by CLIA-certified high complexity laboratories or research laboratories for the qualitative detection of nucleic acid-based analytes. FDA UDI
Model / Reference
APTIMA GPRS, 250 TESTS (REF) FDA UDI
Description
Aptima® General Purpose Reagents, 250 test, box 2 of 2 (2°C to 8°C box). The Aptima® General Purpose Reagents (GPRs) feature Transcription-Mediated Amplification (TMA®) and Hybridization Protection Assay (HPA) technologies. Aptima® GPRs may be used to facilitate the development of tests by CLIA-certified high complexity laboratories or research laboratories for the qualitative detection of nucleic acid-based analytes. FDA UDI

Identifiers

Catalog Number
302071 FDA UDI
Primary DI / UDI-DI
15420045506442 FDA UDI
FDA Product Code
PPM FDA UDI
GMDN Term
Multiple-type sexually transmitted pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.4010 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple-type sexually transmitted pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Aptima® by Hologic, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple-type sexually transmitted pathogen nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Hologic, Inc.

Sources (1)

  • FDA UDI d397d8dd-bb3f-4a4a-9f12-1d12c2f89b35 36 fields · synced May 30, 2026